Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape is a research paper published in BMC Medical Genomics (2020). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: ZIA BC 011300
National Cancer Institute
Grant: ZIA BC 010626
FWCI
3.15
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
Additional file 1 of Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
Additional file 2 of Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
Additional file 2 of Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape